Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

inotersen (Tegsedi)

Source date not recordedAnalyse record ↗

ASO (anti-sense oligonucleotide) to reduce TTR production made by Akcea Therapeutics, which was acquired by Ionis Pharmaceuticals, approved for hATTR.

Modality
subcutaneous injection
Availability (US)
by prescription (very expensive), but only for hATTR for now
Biomarkers
ATTR scan
Hallmark targeted
proteostasis / ATTR tx
Kind
age slowing
Clinical trials
11 listed